Lincoln National Corporation LNC
41.96 USD +0.16 (+0.38%)
Regular-session close
41.96 0.00 0.00%
After hours · Nov 13, 4:01 PM ET
41.38 Day range 42.25
32.59 52-week range 47.00
- YTD
- -5.77%
- 1 year
- +2.14%
News
benzinga.com Wells Fargo Maintains Overweight on Lincoln National, Lowers Price Target to $53 Wells Fargo analyst Wesley Carmichael maintains Lincoln National (NYSE:LNC) with a Overweight and lowers the price target from $54 to $53.
defenseworld.net Lincoln National Corporation $LNC Stake Increased by Allspring Global Investments Holdings LLC Allspring Global Investments Holdings LLC increased its holdings in shares of Lincoln National Corporation (NYSE: LNC) by 40.1% in the third quarter, according to the company in its most recent…
businesswire.com Lincoln National Corporation's Board of Directors Declares Quarterly Cash Dividend RADNOR, Pa.--(BUSINESS WIRE)--Lincoln Financial (NYSE:LNC) announced today that the board of directors of Lincoln National Corporation declared a quarterly cash dividend of $0.45 per share on the…
gurufocus.com Lincoln Financial Research Finds 80% of Families Haven't Had In-Depth Conversations About Age-Related Healthcare Costs As Americans live longer and face an increasing likelihood of needing long-term care, new research from Lincoln Financial reveals that many families are avoidin
marketbeat.com What Lincoln National (LNC) Said on Its Q3 Earnings Call Lincoln National NYSE: LNC reported third-quarter 2026 adjusted operating income of $339 million, or $1.72 per diluted share, as stronger life insurance and retirement plan results helped offset…
benzinga.com Lincoln National Q3 2026 Earnings Call Transcript Lincoln National (NYSE:LNC) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Lincoln National Q3 Adj. EPS $1.72 Misses $1.96 Estimate, Sales $5.481B Beat $4.955B Estimate Lincoln National (NYSE:LNC) reported quarterly earnings of $1.72 per share which missed the analyst consensus estimate of $1.96 by 12.24 percent. This is a 15.69 percent decrease over earnings of…- benzinga.com JP Morgan Maintains Underweight on Lincoln National, Lowers Price Target to $47 JP Morgan analyst Pablo Singzon maintains Lincoln National (NYSE:LNC) with a Underweight and lowers the price target from $49 to $47.
benzinga.com Wells Fargo Maintains Overweight on Lincoln National, Raises Price Target to $54 Wells Fargo analyst Wesley Carmichael maintains Lincoln National (NYSE:LNC) with a Overweight and raises the price target from $52 to $54.
benzinga.com Keefe, Bruyette & Woods Maintains Outperform on Lincoln National, Lowers Price Target to $50 Keefe, Bruyette & Woods analyst Ryan Krueger maintains Lincoln National (NYSE:LNC) with a Outperform and lowers the price target from $51 to $50.
benzinga.com Mizuho Maintains Outperform on Lincoln National, Lowers Price Target to $49 Mizuho analyst Yaron Kinar maintains Lincoln National (NYSE:LNC) with a Outperform and lowers the price target from $53 to $49.
benzinga.com Barclays Maintains Overweight on Lincoln National, Raises Price Target to $48 Barclays analyst Alex Scott maintains Lincoln National (NYSE:LNC) with a Overweight and raises the price target from $45 to $48.- benzinga.com Evercore ISI Group Maintains In-Line on Lincoln National, Lowers Price Target to $51 Evercore ISI Group analyst Thomas Gallagher maintains Lincoln National (NYSE:LNC) with a In-Line and lowers the price target from $52 to $51.
- benzinga.com UBS Maintains Neutral on Lincoln National, Raises Price Target to $46 UBS analyst Michael Ward maintains Lincoln National (NYSE:LNC) with a Neutral and raises the price target from $44 to $46.
benzinga.com Morgan Stanley Maintains Overweight on Lincoln National, Lowers Price Target to $47 Morgan Stanley analyst Bob Huang maintains Lincoln National (NYSE:LNC) with a Overweight and lowers the price target from $50 to $47.
benzinga.com IBM To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday Top Wall Street analysts changed their outlook on these top names. For a complete view of all rating changes, see analyst ratings page.
benzinga.com Earnings Scheduled For February 12, 2026 
benzinga.com Under the Radar: Why Process Beats Prediction in Volatile Markets 
benzinga.com 10 Financials Stocks With Whale Alerts In Today's Session 
benzinga.com Earnings Scheduled For October 30, 2025 - benzinga.com Earnings Scheduled For July 31, 2025
benzinga.com 5 Undervalued Dividend Stocks To Buy As Rally Gets Overextended Here are five finance firms with high Benzinga Edge Value scores that also offer steady dividend yields. Let's take a look.
benzinga.com Easy Income Portfolio: June 2025 Update 
benzinga.com Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says U.S. stocks rallied Thursday after the Trump administration signed its first major trade agreement with the United Kingdom, igniting optimism about further global deals — especially with China — and…- benzinga.com Earnings Scheduled For May 8, 2025
- benzinga.com Earnings Scheduled For February 6, 2025
- benzinga.com Insurance Stocks Moving In Tuesday's Intraday Session
- benzinga.com Earnings Scheduled For February 8, 2024 Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
benzinga.com Insurance Stocks Moving In Monday's Intraday Session - benzinga.com Earnings Scheduled For November 1, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
- benzinga.com Insurance Stocks Moving In Monday's Intraday Session
- benzinga.com Insurance Stocks Moving In Friday's Intraday Session
- benzinga.com Insurance Stocks Moving In Friday's Intraday Session
- benzinga.com Earnings Scheduled For August 2, 2023 Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
- benzinga.com Insurance Stocks Moving In Tuesday's Intraday Session
- benzinga.com Insurance Stocks Moving In Wednesday's Intraday Session
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 117 stocks hit new 52-week lows.
- benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 469 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 337 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 479 stocks made new 52-week lows.- benzinga.com Earnings Scheduled For February 8, 2023 Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is likely to report earnings for its fourth quarter. • Bunge (NYSE:BG) is projected to report quarterly earnings at $3.22 per share on…
- benzinga.com Insurance Stocks Moving In Thursday's Intraday Session
benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's trading, 293 companies set new 52-week lows.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 236 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For November 2, 2022 Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For August 3, 2022 Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For May 4, 2022 Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.